HarborOne Bancorp (NASDAQ:HONE) Bolsa

HarborOne Bancorp

HarborOne Bancorp Inc is a bank holding company. The company is engaged in providing financial services like accepting deposits, lending loans, online and mobile banking, cash management, credit cards, money market accounts, and wealth management. The Company has two reportable segments: HarborOne Bank and HarborOne Mortgage. The bank provides financial services to individuals and businesses online and through its full-service branches located in Massachusetts and Rhode Island, one limited-service branch, and a commercial lending office in Boston, Massachusetts, and Providence, Rhode Island.

Advanced Environmental Recycling Technologies

AERT

AILE

CTXR

HONE

HSON

INTZ

KORE

LITM

NATR

PDYN

REKR

SLDP

VINC

WATT

Descubre los mayores ganadores y perdedores en el mercado previo tras movimientos impactantes en acciones clave hoy.

Las acciones de Vincerx Pharma (VINC) suben alrededor del 64%; 20 acciones que se mueven en premercado

Shares of Plug Power Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) are trading higher Thursday morning as positive sentiment from Wall Street analysts appears to be overshadowing recent dilution concerns. The stock&#8217;s rally is gaining momentum following a series of price target increases from financial firms this week.
What To Know: The renewed optimism provides a strong tailwind after a volatile period for the hydrogen fuel cell company. Last week, shares slid after a July 9 prospectus filing detailed the potential resale of <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46398722/plug-powers-hot-streak-stalls-as-wall-street-frets-over-warrant-surprise">31.5 million shares</a> by a stockholder, stoking fears of share dilution.
However, a string of bullish catalysts is now commanding investor attention. On Monday, Susquehanna <a href="https://www.benzinga.com/quote/PLUG/analyst-ratings">raised</a> its price target on PLUG to $1.80. Jefferies followed on Wednesday, maintaining a Hold rating but nearly doubling its price target from 90 cents to $1.60.
This analyst confidence builds on fundamental progress, including a new low-cost hydrogen supply agreement expected to boost margins and a federal extension of the 45V clean hydrogen tax credit. Furthermore, a 650,000-share purchase by CFO Paul Middleton in June <a href="https://www.benzinga.com/trading-ideas/movers/25/06/46120866/whats-going-on-with-plug-power-stock-12">signaled</a> strong executive confidence. 
Thursday&#8217;s upward momentum suggests investors are prioritizing recent strategic wins and analyst upgrades over dilution fears, setting a bullish tone for the stock ahead of its second-quarter earnings release in August.
Benzinga Edge Rankings: According to <a href="http://benzinga.grsm.io/register174">Benzinga Edge</a> stock rankings, which are designed to identify the strength of a stock across four critical factors, Plug Power presents a distinct profile for investors. 
The company scores exceptionally well on its Value metric with a high score of 73.15, suggesting it may be undervalued relative to its peers or intrinsic worth. In sharp contrast, the data indicates significant weakness in other areas. 
PLUG shows very poor Momentum with a score of 18.84 and weak Growth characteristics, scoring just 15.29. This profile suggests that while PLUG may appeal to value-oriented investors, it currently lacks the strong growth and market momentum that other traders may seek.
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, PLUG shares are trading higher by 4.8% to $1.89 Thursday morning. The stock has a 52-week high of $3.32 and a 52-week low of $0.69.
Read Also: <a href="https://www.benzinga.com/insights/analyst-ratings/25/07/46528280/expert-outlook-plug-power-through-the-eyes-of-6-analysts">Expert Outlook: Plug Power Through The Eyes Of 6 Analysts</a>
<h2 class="wp-block-heading">How To Buy PLUG Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Plug Power&#8217;s case, it is in the Industrials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
Image: Shutterstock

News

PLUG

What's Going On With Plug Power Stock?

JP Morgan analyst Samik Chatterjee maintains TE Connectivity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEL#NYSE">TEL</a>) with a Neutral and raises the price target from $186 to $204.

Price Target

Analyst Ratings

JP Morgan Maintains Neutral on TE Connectivity, Raises Price Target to $204

WIIM

GSHD

Goosehead Insurance shares are trading lower after the company reported mixed Q2 financial results. Also, Piper Sandler downgraded the stock from Overweight to Neutral and lowered its price target from $122 to $109.

<a href="https://www.axios.com/2025/07/24/gaza-ceasefire-talks-israel-recall-negotiators">https://www.axios.com/2025/07/24/gaza-ceasefire-talks-israel-recall-negotiators</a>

General

iShares MSCI Israel Capped Investable Market Index Fund

'Gaza ceasefire talks in limbo as Israel recalls negotiators'- Axios

West Pharmaceutical Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WST#NYSE">WST</a>) shares are surging Thursday after the injectable pharmaceutical packaging and delivery systems company delivered a robust beat on its <a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/n46595840/west-announces-second-quarter-2025-results-and-fourth-quarter-2025-dividend-updates-full-year-2025" rel="noreferrer noopener">second-quarter 2025</a> earnings and revenue, while also significantly raising its full-year guidance.
The strong performance was largely driven by exceptional growth in its High-Value Product (HVP) segment, particularly due to strong demand for GLP-1 elastomer products and ongoing momentum in HVP conversions.
The company reported second-quarter 2025 adjusted earnings of $1.84, up from $1.52 a year ago, beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $1.51</a>. Similarly, sales reached $766.5 million, outperforming the $726.45 million consensus.
Also Read: <a target="_blank" href="https://www.benzinga.com/node/44994926" rel="noreferrer noopener">West Pharmaceutical Defies Doubters: EPS Jumps,&nbsp;Outlook&nbsp;Raised Despite Tariff Drag</a>
Net sales grew by 9.2%. Organic net sales growth was 6.8%. The Proprietary Products Segment&#8217;s sales increased by 10.7% to $619.8 million and 8.4% organically.
High-Value Product (HVP) (components and devices) represented around 47% of total company net sales and increased 11.3%, driven by strength in Westar and NovaChoice products.
Standard Products, 21% of total company net sales, increased by 0.4%. HVP Delivery Devices&nbsp;represented 13% of total company net sales and increased 30.0%, driven mainly by Daikyo Crystal Zenith and Administration Systems.
The company&#8217;s biologics, pharma, and generics market units each had high-single-digit organic net sales growth.
Contract-manufactured products, representing 19% of total company net sales, increased by 3.0% to $146.7 million, or up 0.5% organically. Segment performance was driven by an increase in sales of self-injection devices for obesity and diabetes, partially offset by a decrease in sales of healthcare diagnostic devices.
On Monday, West Pharmaceutical appointed Robert McMahon as the company&#8217;s new Chief Financial Officer, effective August 4. Mr. McMahon will succeed&nbsp;Bernard Birkett, CFO, who announced his intention to <a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/n46513800/west-welcomes-robert-mcmahon-as-incoming-chief-financial-officer" rel="noreferrer noopener">retire earlier this year</a>.
Eric Green, president, CEO and chair of the board, commented, &#8220;I am pleased to report that we exceeded our expectations for the second quarter driven by solid growth in HVP components. This was the result of strong GLP-1 elastomer growth, ongoing momentum in HVP conversion mainly related to Annex 1 projects and the continued normalization of customer ordering patterns. The improved performance was concentrated in higher margin products, which drove strong margin expansion in the quarter.&#8221;
<h2 class="wp-block-heading">Outlook</h2>
West Pharmaceutical Services raised the 2025 adjusted EPS guidance <a target="_blank" href="https://www.benzinga.com/general/health-care/25/04/44994926/west-pharmaceutical-defies-doubters-eps-jumps-outlook-raised-despite-tariff-drag" rel="noreferrer noopener">from $6.15-$6.35</a> to $6.65-$6.85 compared to the consensus of $6.29.
The company said updated adjusted-diluted EPS guidance incorporates our estimate of $15 to $20 million for the net impact of recently implemented tariffs.
The company raised sales guidance from $2.94 billion-$2.98 billion to&nbsp;$3.04 billion-$3.06 billion&nbsp;versus the consensus of&nbsp;$2.96 billion.
Organic net sales growth is expected to be approximately 3% to 3.75%, up from the previous guidance range of 2% to 3%.
Following the company&#8217;s strong second-quarter 2025 earnings report and raised full-year guidance, William Blair maintained its <a target="_blank" href="https://www.benzinga.com/quote/WST/analyst-ratings" rel="noreferrer noopener">Outperform</a> rating on the stock.
&#8220;The rating is predicated on West being a high-quality, franchise name that provides quality and dependable earnings and cash flow, a clear leadership competitive position, and access to attractive end-market trends without single product or technology risk,&#8221; analyst Matt Larew said on Thursday.
Price Action: WST stock is trading higher by 24.95% to $284.02 at last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/earnings/25/07/46597552/dow-cuts-dividend-in-half-as-losses-mount-and-tariffs-amplify-industry-pain" target="_blank" rel="noreferrer noopener">Dow Cuts Dividend In Half As Losses Mount And Tariffs Amplify Industry Pain</a></li>
</ul>
Photo via Shutterstock

Analyst Color

Earnings

Guidance

Health Care

Reiteration

Movers

Trading Ideas

West Pharma Lifts Outlook On Surging GLP-1 Demand, Stock Soars

JP Morgan analyst Sebastiano Petti maintains T-Mobile US (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>) with a Overweight and raises the price target from $270 to $280.

TMUS

JP Morgan Maintains Overweight on T-Mobile US, Raises Price Target to $280

Intel Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) will release earnings results for the second quarter, after the <a href="https://www.benzinga.com/quote/INTC/earnings">closing bell on Thursday, July 24.</a>
Analysts expect the Santa Clara, California-based company to report quarterly earnings at 1 cent per share, down from 2 cents per share in the year-ago period. Intel projects to report quarterly revenue at $11.88 billion, compared to $12.83 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
The company has beaten revenue estimates from analysts in three straight quarters and seven of the last 10 quarters overall.
Intel shares gained 1.1% to close at $23.49 on Wednesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/intc/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Loop Capital analyst Gary Mobley initiated coverage on the stock with a Hold rating and a price target of $25 on July 21, 2025. This analyst has an accuracy rate of 72%.</li>
<li>Stifel analyst Ruben Roy maintained a Hold rating and raised the price target from $21 to $24.5 on July 21, 2025. This analyst has an accuracy rate of 84%.</li>
<li>UBS analyst Timothy Arcuri maintained a Neutral rating and raised the price target from $21 to $25 on July 14, 2025. This analyst has an accuracy rate of 80%.</li>
<li>Citigroup analyst Christopher Danely maintained a Neutral rating and increased the price target from $21 to $24 on July 7, 2025. This analyst has an accuracy rate of 80%.</li>
<li>Mizuho analyst Vijay Rakesh maintained a Neutral rating and raised the price target from $22 to $23 on July 3, 2025. This analyst has an accuracy rate of 78%.</li>
</ul>
Considering buying INTC stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="574" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/24033614/image-353-1024x574.png" alt="" class="wp-image-998496" style="width:555px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/24033614/image-353-1024x574.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/24033614/image-353-300x168.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/24033614/image-353-768x430.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/24033614/image-353.png 1083w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46570034/jim-cramer-likes-stocks-yield-not-fundamentals">Jim Cramer Loves &#8216;That Yield&#8217; But Passes On This Stock: &#8216;Fundamentals Are Hurting&#8217;</a></li>
</ul>
Photo via Shutterstock

Markets

INTC

Intel Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Advanced Micro Devices Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) shares got a boost late Wednesday as aggressive AI plans were unveiled at an AI summit event. Here&#8217;s a look at what you <a href="https://www.benzinga.com/markets/tech/25/07/46593182/trump-signs-new-executive-orders-to-fast-track-ai-dominance-we-will-be-unstoppable-as-a-nation">need to know</a>.
What Happened: President Donald Trump <a href="https://www.benzinga.com/markets/tech/25/07/46593182/trump-signs-new-executive-orders-to-fast-track-ai-dominance-we-will-be-unstoppable-as-a-nation">signed</a> three executive orders late Wednesday outlining an action plan designed to accelerate AI development and position the U.S. at the forefront of the AI race, per Reuters. 
At an AI summit event, Trump signed three executive orders that aim to limit AI regulations and boost innovation, accelerate development of AI infrastructure and promote U.S. AI technology adoption. 
Nvidia CEO Jensen Huang applauded Trump&#8217;s AI action plans late Wednesday and said the leadership approach from the White House gives the U.S. an advantage in the AI race. 
AMD CEO Lisa Su <a href="https://www.benzinga.com/markets/tech/25/07/46594910/lisa-su-says-ai-chip-demand-could-top-500-billion-in-just-a-few-years-says-us-must-rapidly-scale-manufacturing-to-keep-up-with-elon-musk-sam-altman">said</a> at the AI summit on Wednesday that AI chip demand could rise above $500 billion over the coming years, fueled by surging infrastructure demand from hyperscalers and AI companies like OpenAI and xAI.
Trump reportedly recognized both Huang and Su as key leaders helping the U.S. establish a leadership position in AI development. Shares of Nvidia and AMD climbed more than 1% in Wednesday&#8217;s after-hours session as Trump was speaking at the event. 
The pair of chipmaker stocks also appeared to get a boost after Alphabet increased its capital expenditures outlook for 2025 to approximately $85 billion due to "strong and growing demand" for cloud products and services.
Trump is expected to announce additional actions in the coming weeks that will help AI leaders secure the electricity needed to power the data centers that will drive the AI expansion.
Price Action: <a href="http://benzinga.com/quote/NVDA">Nvidia shares</a> were up 0.93% at $172.35 and <a href="http://benzinga.com/quote/AMD">AMD shares</a> were up 0.71% at $159.77 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Nvidia&#8217;s current share price is near the upper end of its 52-week range of $86.62 &#8211; $174.25, indicating strong upward momentum. The stock is trading well above its 50-day moving average of $148.47, suggesting a bullish trend. Key resistance may be encountered around the 52-week high, while support could be found near the 50-day moving average.
AMD is currently trading well above its 50-day moving average of $129.59, indicating strong bullish momentum. Key support levels can be observed around the 200-day moving average at $123.17, while resistance is noted near the 52-week high of $174.05.
Compared to sector peers, AMD&#8217;s P/E ratio of 115.8 is significantly higher than Nvidia&#8217;s 55.09, indicating a more aggressive growth outlook priced into AMD&#8217;s stock.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46594910/lisa-su-says-ai-chip-demand-could-top-500-billion-in-just-a-few-years-says-us-must-rapidly-scale-manufacturing-to-keep-up-with-elon-musk-sam-altman">Lisa Su Says AI Chip Demand Could Top $500 Billion In Just A Few Years — Says US Must Rapidly Scale Manufacturing To Keep Up With Elon Musk, Sam Altman</a></li>
<li><a href="https://www.benzinga.com/markets/tech/25/07/46600247/nvidia-ai-chips-worth-1-billion-flood-chinas-black-market-after-trumps-export-curbs-its-like-a-seafood-market">Nvidia AI Chips Worth $1 Billion Flood China&#8217;s Black Market After Trump&#8217;s Export Curbs: &#8216;It&#8217;s Like A Seafood Market&#8217;</a></li>
</ul>
Photo: gguy/Shutterstock.com

Events

NVDA

What's Going On With Nvidia, AMD Shares Thursday?

JP Morgan analyst Alexei Gogolev maintains SS&amp;C Technologies Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSNC#NASDAQ">SSNC</a>) with a Neutral and raises the price target from $86 to $94.

SSNC

JP Morgan Maintains Neutral on SS&C Technologies Hldgs, Raises Price Target to $94

Matchpoint's approach leverages the properties of covalent chemistry and a proprietary platform to target a novel binding site on a historically hard-to-drug protein. The result is to precisely inhibit that protein's function and the resulting production of pro-inflammatory cytokines and chemokines.
Under the terms of the agreement, Matchpoint will utilize its Advanced Covalent Exploration (ACE)&#x2122;&nbsp;platform to advance its preclinical program through development candidate selection. Matchpoint will lead all research activities to that point and will receive research funding from Novartis. If Novartis exercises its option to exclusively license the program, Novartis will have global rights to develop and commercialize all products resulting from the collaboration. Matchpoint is eligible to receive up to $1 billion in total payments, including development and commercial milestones, plus tiered royalties on future product sales.

Biotech

Large Cap

Contracts

Earlier On Thursday, Matchpoint Therapeutics Announced An Exclusive Option And License Agreement With Novartis For Oral Covalent Inhibitors Directed At A Transcription Factor Linked To Inflammatory Diseases, Matchpoint To Receive Up To $60M In Upfront Payment And Research Funding, With Up To $1B In Total Potential Payments

SIGI

Selective Insurance Group shares are trading lower after the company reported worse-than-expected Q2 financial results.

JP Morgan analyst Michael Cho maintains Raymond James Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RJF#NYSE">RJF</a>) with a Neutral and raises the price target from $151 to $172.

JP Morgan Maintains Neutral on Raymond James Finl, Raises Price Target to $172

SS&amp;C Technologies Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSNC#NASDAQ">SSNC</a>) has outperformed the market over the past 15 years by 9.84% on an annualized basis producing an average annual return of 22.21%. Currently, SS&amp;C Technologies Hldgs has a market capitalization of $21.39 billion. 
Buying $100 In SSNC: If an investor had bought $100 of SSNC stock 15 years ago, it would be worth $2,075.73 today based on a price of $86.36 for SSNC at the time of writing.
<h3>SS&amp;C Technologies Hldgs's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1753367420_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In SS&C Technologies Hldgs 15 Years Ago Would Be Worth Today

Macro Economic Events

Econ #s

Economics

USA Natural Gas Storage 23B Vs 28B Est.

JP Morgan analyst Michael Rehaut maintains NVR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVR#NYSE">NVR</a>) with a Neutral and raises the price target from $7200 to $7600.

JP Morgan Maintains Neutral on NVR, Raises Price Target to $7600

Options

OPEN

Opendoor Technologies Option Alert: Fri $3 Calls Sweep (65) near the Ask: 2786 @ $0.301 vs 42656 OI; Earnings 8/5 After Close Ref=$2.875

ASGN

ASGN shares are trading higher after the company reported better-than-expected Q2 financial results.

JP Morgan analyst Andrew Steinerman maintains Moodys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCO#NYSE">MCO</a>) with a Overweight and raises the price target from $565 to $570.

JP Morgan Maintains Overweight on Moodys, Raises Price Target to $570

LKQ shares are trading lower after the company reported worse-than-expected Q2 adjusted EPS results and cut its FY25 GAAP EPS and adjusted EPS guidance below estimates.

JP Morgan analyst Christopher Horvers maintains Mattel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAT#NASDAQ">MAT</a>) with a Neutral and raises the price target from $23 to $25.

JP Morgan Maintains Neutral on Mattel, Raises Price Target to $25

Press Releases

HarborOne Bancorp, Inc. Announces 12.5% Increase in First Quarter 2025 Dividend

HarborOne Bancorp, Inc. Announces 2025 First Quarter Results

Eastern Bankshares, Inc. and HarborOne Bancorp, Inc. Enter Into Definitive Agreement To Merge

HONE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of HarborOne Bancorp Is Fair to Shareholders

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of HarborOne Bancorp, Inc.

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of HarborOne Bancorp - HONE

HARBORONE BANCORP INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of HarborOne Bancorp - HONE

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COLB, PPBI, HONE on Behalf of Shareholders

HarborOne Bancorp, Inc. Declares Second Quarter 2025 Dividend

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HONE, FL, SAGE on Behalf of Shareholders

Comments

HarborOne Bancorp

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL